Replikins

Replikins is a biotechnology company that specializes in the prediction of viral outbreaks and the development of synthetic peptide vaccines. The company's proprietary technology centers on "Replikin" sequences, which are specific lysine-rich peptide motifs identified in the proteins of rapidly replicating pathogens and cancer cells. Using its BioRadar surveillance system, Replikins monitors genomic data to forecast the emergence of virulent strains of diseases such as influenza, SARS, and Zika. The company aims to produce low-cost, rapidly synthesized vaccines that can be deployed quickly in response to pandemic threats. Despite its innovative approach to pandemic preparedness, the company's methods have faced scrutiny regarding their scientific validation and independent peer review.